Cervical plexus anesthesia for carotid endarterectomy: comparison of ropivacaine and mepivacaine

Citation
A. Leoni et al., Cervical plexus anesthesia for carotid endarterectomy: comparison of ropivacaine and mepivacaine, CAN J ANAES, 47(2), 2000, pp. 185-187
Citations number
10
Categorie Soggetti
Aneshtesia & Intensive Care","Medical Research Diagnosis & Treatment
Journal title
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE
ISSN journal
0832610X → ACNP
Volume
47
Issue
2
Year of publication
2000
Pages
185 - 187
Database
ISI
SICI code
0832-610X(200002)47:2<185:CPAFCE>2.0.ZU;2-L
Abstract
Purpose: To evaluate the effectiveness of cervical plexus block performed w ith ropivacaine 0.75% or 1%, or mepivacaine 2%, Methods: In a prospective randomized, double-blind study, 60 patients recei ved deep cervical plexus block with 0.2 ml.kg(-1) divided among C-2-C-4 inj ections using ropivacaine 0.75% and 1% or mepivacaine 2%, A blinded observe r recorded loss of pin-prick sensation every minute in the C-2-C-4 dermatom es unlit readiness for surgery, Then, a superficial cervical block was perf ormed with 0.15 ml.kg(-1) lidocaine 1%. The need for intraoperative supplem ental analgesia and degree of pain and time of first postoperative pain med ication were also recorded. Results: General anesthesia was not required to complete surgery in any cas e, No differences in the need for intraoperative supplemental analgesia was observed (7, 6, and 9 patients with ropivacaine 0.75% and 1% or mepivacain e 2%, respectively). Readiness to surgery required 15 (10 - 25) min with ro pivacaine 0.75%, 18 (8 - 20) min with ropivacaine 1%, and 15 (5 - 20) min w ith mepivacaine 2% (P = NS); while patients asked for first postoperative p ain medication after 10 (4 - 13) hr and 9 (6.5 - 11) hr with ropivacaine 0. 75% and 1% compared with 5 (0 - 8) hr with mepivacaine 2% (P < 0.05), Conclusion: Ropivacaine 0.75% or 1% are appropriate choices when performing cervical plexus anesthesia for carotid endarterectomy, providing nerve blo ck characteristics similar to those of mepivacaine 2%, but with the advanta ge of longer postoperative pain relief.